Resolution; Hypertrophic Cardiomyopathy Awareness Day.
House Resolution 1005 is a ceremonial resolution recognizing February 26, 2025, as Hypertrophic Cardiomyopathy Awareness Day at the Oklahoma State Capitol. The resolution describes hypertrophic cardiomyopathy (HCM) as a chronic inherited heart disease that can cause serious complications such as heart failure, atrial fibrillation, stroke, and, in rare cases, sudden cardiac death. It emphasizes that HCM is common, often undiagnosed, and can be difficult to distinguish from other cardiovascular or pulmonary conditions because of overlapping symptoms like shortness of breath, chest pain, fatigue, palpitations, and fainting.
The resolution also highlights the importance of early recognition, medical history, screening, and diagnostic testing such as echocardiograms, cardiac MRI, and genetic testing. It encourages patients to work with health care providers to understand treatment and management options, including medications and surgery. The measure does not create a new regulatory program or mandate health coverage, but instead serves as a public awareness statement by the Oklahoma House of Representatives and the State of Oklahoma.
HR1005 has no direct legal or regulatory effect on Oklahoma statutes, agencies, or private parties. It is a nonbinding resolution that formally designates a day of awareness and expresses legislative support for public education about hypertrophic cardiomyopathy, with the practical effect of promoting outreach, screening awareness, and discussion of cardiovascular health rather than changing state law.
The sentiment around the resolution is strongly supportive and noncontroversial. The text frames HCM awareness as an important public health issue and presents the resolution as a way to improve cardiovascular health and encourage appropriate care for undiagnosed or untreated cases. No committee debate, recorded votes, or opposition are provided in the available materials, suggesting the measure was treated as a consensus awareness resolution.
No specific points of contention are evident in the bill text or available legislative history. Because the measure is a commemorative and educational resolution rather than a policy change, there is no indication of disagreement over funding, mandates, insurance coverage, or state program administration. The only substantive emphasis is on the importance of awareness, diagnosis, and treatment of HCM, which appears to have broad support.